News
Yposkesi launches AAVelocity™, a plug-and-play Adeno-Associated Virus (AAV) platform
7 November 2023
SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough Medicines
20 September 2023
Yposkesi inaugurates €60M biomanufacturing site for cell and gene therapies
22 June 2023Blog
Case Study: Evaluation of several process cell lysis reagents as replacements for Triton X-100 for rAAV production.
14 November 2023
Podcast: Building with the patient in mind: Designing a state-of-the-art facility for viral vector manufacturing
13 October 2023
